| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Flunitrazepam and Metabolites, Quantitative, Urine
Test Code18886
Includes
Flunitrazepam, 7-Aminoflunitrazepam, N-Desmethylflunitrazepam
Preferred Specimen
2 mL urine in a sterile leak-proof container
Minimum Volume
1 mL
Instructions
Do not use any preservatives or additives
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: Unacceptable
Refrigerated: 14 days
Frozen: 60 days
Refrigerated: 14 days
Frozen: 60 days
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Thurs ; Report available: 2-8 days
Clinical Significance
In Latin America and Europe, Rohypnol (Flunitrazepam) is prescribed as a short-term treatment for insomnia, and as preanesthetic medication.
Flunitrazepam is considered a drug of abuse when used to enhance the effect of other substances such as marijuana, heroin, and ethanol. The combination of ethanol and flunitrazepam may lead to sedation, loss of motor function, impaired judgment, behavioral changes, and anterograde amnesia.
Flunitrazepam is considered a drug of abuse when used to enhance the effect of other substances such as marijuana, heroin, and ethanol. The combination of ethanol and flunitrazepam may lead to sedation, loss of motor function, impaired judgment, behavioral changes, and anterograde amnesia.
